Crossmark

Compliance with the guidelines on recommended immunization schedule in patients with inflammatory bowel disease: implications on public health policies

Crossref DOI link: https://doi.org/10.1186/s12889-020-08850-y

Published Online: 2020-05-19

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

García-Serrano, Cristina

Mirada, Glòria

Marsal, Josep R

Ortega, Marta

Sol, Joaquim http://orcid.org/0000-0003-1424-8958
Solano, Rubén

Artigues, Eva M

Estany, Pepi
License Information

Text and Data Mining valid from 2020-05-19

Version of Record valid from 2020-05-19
More Information

Article History

Received: 14 January 2020

Accepted: 5 May 2020

First Online: 19 May 2020

Ethics approval and consent to participate

: This study was approved by the ethics and clinical research committee at the <i>Institut d’Investigació IDIAP Jordi Gol</i> under the code P17/226. The study was conducted in accordance with the principles of the Declaration of Helsinki. Information was obtained from electronic medical records stored in the centralized ECAP database and was extracted by the Department of Healthcare Evaluation and Research Management. Accordingly, it was not necessary to ask participants for their informed consent. The variables in the ECAP database were processed anonymously and with full confidentiality guarantees as established by national law and Regulation 2016/679 of the European Parliament and of the Council on the protection of natural persons with regard to the processing of personal data and on the free movement of such data.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below